In another retrospective cohort enrolling patients with CD19+ R/R NHL and chronic lymphocytic leukemia, a CAR construct containing a CD28 costimulatory domain and coexpressing truncated epidermal growth factor receptor was used to generate CD19CAR-T cells. Here, CD19 is linked to non-Hodgkin lymphoma.